Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Do Politics Affect Cannabis' Long-Term Growth Story? (Transcript)

Aurora Cannabis

HEXO Corp

Legalization. It's not just for marijuana anymore.

Why Marijuana Stocks Got Stubbed Out Today

Intercure Ltd

cbdMD Inc

Clever Leaves Holdings Inc

Evogene

Flora Growth Corp

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

These Pot Stocks Made Major International Moves This Week

The downward trend on TLRY stock might soon come to an end, amid an encouraging financial picture and increasing rumors that the cannabis legislation is close to a loosening in its core markets. The post Tilray' Downtrend Should Soon Come to an End appeared first on InvestorPlace.

Tilray' Downtrend Should Soon Come to an End

Tilray Medical's portfolio of medical cannabis brands includes Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany.

Tilray Launches Medical Cannabis Products In Malta.

LEAMINGTON, Ontario, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has completed its first sale of medical cannabis in Malta. Tilray's EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis.

Tilray Launches Medical Cannabis Products in Malta

Federal cannabis legalization is not the end all, be all - investors would be wise to think it will take longer than expected.

Do Politics Affect Cannabis' Long-Term Growth Story?

OrganiGram Holdings Inc.

SNDL Inc.

There's a promising development in one U.S. state.

Why Marijuana Stocks Like Aurora Cannabis Rose So Much Today

High Tide

Top Pot Stocks To Watch On The Nasdaq The post Top Canadian Marijuana Stocks To Buy? 3 To Watch Now In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Buy? 3 To Watch Now In February 2022

This article was originally published on Cannabis.net and appears here with permission. In December 2021, Tilray (NASDAQ:TLRY) made headlines by purchasing Breckenridge Distillery, a Colorado-based distiller, in a large deal valued at $102.9 million with the intentions of infusing whiskey with cannabis.

Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

Coinbase

Coupang

DraftKings

Riot Blockchain

Skillz

XPeng

Growth stocks that can deliver robust returns in 2022. Stocks that are likely to be supported by positive industry tailwinds.

7 Monster Growth Stocks to Buy for 2022 and Beyond

CEA Industries

Leafly Holdings

WM Technology

Neptune Wellness Solutions Inc.

Catch Up On the Busiest Week For Cannabis Stocks of 2022

US legal cannabis sales reached $25B in 2021, accounting for the lion's share of 80.6% of global sales, while international sales (excluding the US) only reported $6B of sales.

Tilray Brands: The Big Money Is Still In The US

BRECKENRIDGE, Colo., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Breckenridge Distillery, a business wholly-owned by a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced the second release of their highly anticipated and limited-edition beer-barrel whiskey, 'Super' Sexy Motor Oil, for this Valentine's Day. Produced in collaboration with Breckenridge Brewery, series two of ‘Super' Sexy Motor Oil brings the unique flavors of coffee and coconut.

Breckenridge Distillery Announces Second Series of ‘Super' Sexy Motor Oil Launching in Limited Edition for Valentine's Day

Cannabis stocks are up today as some companies report earnings. Sundial Growers has its own cause to celebrate as its story continues.

Cannabis Stocks Alert: Why Are SNDL, CGC, TLRY, ACB Stocks Are Getting High Today?

Tilray Inc. TLRY shares were trading higher Wednesday after the company announced it is expanding across California with distribution partners Reyes Beer Division. This ties together the continued westward expansion of SweetWater with the opening of SweetWater Colorado Brewing Company, LLC in Fort Collins, Colorado.

Tilray Stock Is Having A Green Day: What's Going On?

11 th Largest Craft Brewer in the U.S., SweetWater, Launches Partnership with the Country's Largest Beer Distributor, Reyes Beer Division

SweetWater Brewing Company Expands Distribution Across California

The stock price of Tilray Inc (NASDAQ: TLRY) increased by 3.65% in the most recent trading session. This is why it happened.

Tilray (TLRY) Stock: Why The Price Increased

Aphria

Tilray Inc. TLRY, +1.34% said Tuesday it created its new Tilray Medical unit by combining the medical divisions of Tilray and Aphria. The move comes after Tilray acquired Aphria in May, 2021.

Tilray combines Aphria medical business under new unit

New Division Brings Together the Legacy Tilray and Aphria Medical Businesses; Includes Expanded Offerings in Canada New Division Brings Together the Legacy Tilray and Aphria Medical Businesses; Includes Expanded Offerings in Canada

Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and Products

Marijuana stocks in Canada continue to tumble as fierce competition prevents the big brands on U.S exchanges from capturing a larger share of the Canadian market. So, which Canadian marijuana stocks should investors keep a close eye on?

2 Canadian marijuana stocks to keep a close eye on

TLRY stock isn't necessarily an opportunity to buy the dip. Market forces will likely lead Tilray even lower before we see a recovery.

Why Tilray Keeps Expanding and the Stock Keeps Suffering

It has been more than three years since Canada legalized marijuana, but many producers in the country continue to struggle.

4 Eye-Popping Charts Depicting the State of the Canadian Pot Market

Cronos Group

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag

Marijuana banking legislation advances in the House. But will it make a difference?

Why Marijuana Stocks Hit a Pot-Hole Today

News for Tilray Brands Stock (TLRY)